Sign in
4

Changes in Ownership

Milestone Pharmaceuticals Inc. Filed Acc 0001943112-26-000004

Options or other derivatives

  • Chief Operating Officer acquired 340,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Nelson Jeffrey Edward · Chief Operating Officer

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-02-02 Grant or award : show line 1 in the form Employee Stock Option (right to buy) +204,000 204,000 D
2026-02-02 Grant or award : show line 2 in the form Restricted Stock Unit +136,000 136,000 D
Loading xslF345X05/form4-02042026_050205.xml…